Holen Sie sich die Stockscreener-App
6.835
0.51%
-0.035
Schlusskurs vom Vortag:
$6.87
Offen:
$6.8
24-Stunden-Volumen:
835
Relative Volume:
0.04
Marktkapitalisierung:
$61.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.26%
1M Leistung:
+0.96%
6M Leistung:
+35.88%
1J Leistung:
+13.92%
1-Tages-Spanne:
$6.80
$6.835
1-Wochen-Bereich:
$6.66
$6.87
52-Wochen-Spanne:
$3.79
$7.66
Neuehealth Inc Stock (NEUE) Company Profile
Firmenname
Neuehealth Inc
Sektor
Branche
Telefon
612-238-1321
Adresse
9250 NW 36TH STREET, DORAL
Vergleichen Sie NEUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUE
Neuehealth Inc
|
6.835 | 60.81M | 0 | 0 | 0 | 0.00 |
|
UNH
Unitedhealth Group Inc
|
304.72 | 267.61B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
377.05 | 84.95B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
314.99 | 84.22B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
63.60 | 77.60B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
231.39 | 27.35B | 117.76B | 1.21B | 2.39B | 9.95 |
Neuehealth Inc Stock (NEUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-03-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-03-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-03-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-11-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-19 | Eingeleitet | Goldman | Buy |
| 2021-07-19 | Eingeleitet | JP Morgan | Neutral |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-07-19 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Neuehealth Inc Aktie (NEUE) Neueste Nachrichten
Northern Trust Corp Increases Stock Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World
NeueHealth Inc Holds Annual Stockholders Meeting - TipRanks
NeueHealth (NYSE:NEUE) Trading Down 2% – What’s Next? - Defense World
How Bright Health went from insurtech darling to cautionary tale - Modern Healthcare
neueHealth CFO Matushak sells $3,190 in common stock By Investing.com - Investing.com India
neueHealth CFO Matushak sells $3,190 in common stock - Investing.com Australia
NeueHealth Inc. Reports Strong Start to 2025 - TipRanks
UnitedHealth’s financial miscues, and an $800 million revenue cycle bonanza - statnews.com
NeueHealth, Inc. SEC 10-Q Report - TradingView
NeueHealth Q1 2025 slides: improved margins offset revenue decline - Investing.com
NeueHealth: Q1 Earnings Snapshot - New Haven Register
Earnings call transcript: NeueHealth’s Q1 2025 sees strong consumer growth By Investing.com - Investing.com Nigeria
NeueHealth Inc (NEUE) Q1 2025 Earnings Call Highlights: Strong Consumer Growth and Continued ... By GuruFocus - Investing.com Canada
NeueHealth Inc. Reports Strong Q1 2025 Performance - TipRanks
NeueHealth Inc Approves Merger with NH Holdings - TipRanks
NeueHealth to go private after shareholder vote - Modern Healthcare
NeueHealth Inc reports results for the quarter ended March 31Earnings Summary - TradingView
NeueHealth Q1 2025 slides: improved margins offset revenue decline By Investing.com - Investing.com Nigeria
Earnings call transcript: NeueHealth’s Q1 2025 sees strong consumer growth - Investing.com
NeueHealth, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
NeueHealth Reports First Quarter 2025 Results - Business Wire
Renaissance Technologies LLC Sells 1,500 Shares of NeueHealth, Inc. (NYSE:NEUE) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Short Interest in NeueHealth, Inc. (NYSE:NEUE) Declines By 65.9% - Defense World
Former Bright Health, once a Minnesota IPO darling, goes private in $1.3B deal - MSN
Investor Sues To Halt 'Cheap' VC Buyout Of Fla. Health Co. - Law360
NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025 - Bluefield Daily Telegraph
NeueHealth (NYSE:NEUE) Trading Up 1.3% – Still a Buy? - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEUE, BRKL, JWN on Behalf of Shareholders - marketscreener.com
NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc.NEUE - Business Wire
NeueHealth StockIs the Proposed Acquisition of NeueHealth By An Affiliate of Its Controlling Shareholder Fair to NEUE Shareholders?Kehoe Law Firm, P.C. Investigating - ACCESS Newswire
NeueHealth, Inc. (NYSE:NEUE) Q4 2024 Earnings Call Transcript - MSN
Virtu Financial LLC Takes Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World
NeueHealth Inc. Earnings Call Highlights Growth and Acquisition - TipRanks
NeueHealth Inc. (NEUE) reports earnings - Quartz
NeueHealth: Q4 Earnings Snapshot - Midland Daily News
NeueHealth Inc (NEUE) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
NeueHealth Inc. Reports Strong 2024 Financial Performance - TipRanks
NeueHealth Inc reports results for the quarter ended December 31Earnings Summary - TradingView
NeueHealth Q4 Net Loss Narrows, Stock Up In Pre-market - Nasdaq
Finanzdaten der Neuehealth Inc-Aktie (NEUE)
Es liegen keine Finanzdaten für Neuehealth Inc (NEUE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
2.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):